IFNA1 and infection: Kostadinova et al. [24] showed that ATX alterations during HCV infection were reversible within 6 months of initiating IFN-free DAA therapy, but they only included 29 patients with HCV mono-infection and ATX was tested at only 2 points: baseline and week 20–24 of treatment.